NICOLE STEWART: Open Payments
NPI 1114771102 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 46 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $223 |
| Novo Nordisk Inc | 16 | $208 |
| AstraZeneca Pharmaceuticals LP | 3 | $165 |
| Janssen Biotech, Inc. | 1 | $150 |
| Axsome Therapeutics, Inc. | 2 | $147 |
| ABBVIE INC. | 6 | $135 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $31 |
| BETA BIONICS, INC. | 1 | $26 |
Products named: RYBREVANT, Auvelity, BREZTRI, ZEPBOUND, QULIPTA, MOUNJARO, Wegovy, Rybelsus.
Industry payments across TX — which companies pay providers there.
